To Evaluate the Safety, Efficacy,and Pharmacokinetics of Orally Administered Prolectin-M
Clinical trial NCT05733780 · UNKNOWN
Trial details
- NCT number
- NCT05733780
- Sponsor
- Bioxytran Inc.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-01
- Primary completion
- 2023-12-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.